Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liquid AbobotulinumtoxinA for Glabellar Lines
NCT02353871Phase 3Completed
- Sponsor
- Ipsen
- Start
- Jan 2015
- Primary completion
- Apr 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 3 trial of abobotulinumtoxinA in glabellar lines, sponsored by Ipsen. Started Jan 2015; status: completed.
02
Drugs
abobotulinumtoxinA
03
Conditions
glabellar lines
Beyond the preview
Go deeper on NCT02353871.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02353871.